- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
- Report
- August 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
Zileuton is a medication used to treat asthma and other respiratory conditions. It is a leukotriene inhibitor, meaning it works by blocking the production of leukotrienes, which are chemicals that cause inflammation in the airways. Zileuton is available in both oral and inhaled forms, and is typically prescribed for long-term use. It is often used in combination with other medications to control asthma symptoms.
The Zileuton market is a subset of the larger respiratory drugs market, which includes medications used to treat a variety of respiratory conditions. The market is highly competitive, with a number of companies offering products that are similar in terms of efficacy and safety.
Some of the companies in the Zileuton market include GlaxoSmithKline, Merck, AstraZeneca, and Boehringer Ingelheim. Show Less Read more